Lam Research Corporation (BCBA:LRCX)

Orchard Therapeutics Statistics

Total Valuation

Lam Research has a market cap or net worth of ARS 175.35 trillion. The enterprise value is 172.84 trillion.

Market Cap	175.35T
Enterprise Value	172.84T

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	Jun 18, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.26%
Shares Change (QoQ)	-0.87%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.26B

Valuation Ratios

The trailing PE ratio is 27.56 and the forward PE ratio is 23.96.

PE Ratio	27.56
Forward PE	23.96
PS Ratio	8.01
PB Ratio	14.97
P/TBV Ratio	18.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.89, with an EV/FCF ratio of 26.89.

EV / Earnings	27.17
EV / Sales	7.12
EV / EBITDA	20.89
EV / EBIT	22.26
EV / FCF	26.89

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.45.

Current Ratio	2.21
Quick Ratio	1.49
Debt / Equity	0.45
Debt / EBITDA	0.71
Debt / FCF	0.83
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 58.24% and return on invested capital (ROIC) is 26.20%.

Return on Equity (ROE)	58.24%
Return on Assets (ROA)	18.40%
Return on Invested Capital (ROIC)	26.20%
Return on Capital Employed (ROCE)	39.93%
Revenue Per Employee	1.18B
Profits Per Employee	342.06M
Employee Count	17,450
Asset Turnover	0.92
Inventory Turnover	2.22

Taxes

In the past 12 months, Lam Research has paid 712.34 billion in taxes.

Income Tax	712.34B
Effective Tax Rate	10.07%

Stock Price Statistics

The stock price has increased by +1,175.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1,175.63%
50-Day Moving Average	2,117.60
200-Day Moving Average	1,738.50
Relative Strength Index (RSI)	62.87
Average Volume (20 Days)	10,191

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.78

Income Statement

In the last 12 months, Lam Research had revenue of ARS 21.89 trillion and earned 6.36 trillion in profits. Earnings per share was 4,927.71.

Revenue	21.89T
Gross Profit	10.66T
Operating Income	7.01T
Pretax Income	7.07T
Net Income	6.36T
EBITDA	7.47T
EBIT	7.01T
Earnings Per Share (EPS)	4,927.71

Balance Sheet

The company has 7.59 trillion in cash and 5.32 trillion in debt, giving a net cash position of 2.26 trillion.

Cash & Cash Equivalents	7.59T
Total Debt	5.32T
Net Cash	2.26T
Net Cash Per Share	n/a
Equity (Book Value)	11.71T
Book Value Per Share	9,229.38
Working Capital	9.44T

Cash Flow

In the last 12 months, operating cash flow was 7.33 trillion and capital expenditures -901.46 billion, giving a free cash flow of 6.43 trillion.

Operating Cash Flow	7.33T
Capital Expenditures	-901.46B
Free Cash Flow	6.43T
FCF Per Share	n/a

Margins

Gross margin is 48.71%, with operating and profit margins of 32.01% and 29.06%.

Gross Margin	48.71%
Operating Margin	32.01%
Pretax Margin	32.32%
Profit Margin	29.06%
EBITDA Margin	34.10%
EBIT Margin	32.01%
FCF Margin	29.37%

Dividends & Yields

This stock pays an annual dividend of 10.96, which amounts to a dividend yield of 0.44%.

Dividend Per Share	10.96
Dividend Yield	0.44%
Dividend Growth (YoY)	96.78%
Years of Dividend Growth	3
Payout Ratio	21.45%
Buyback Yield	2.26%
Shareholder Yield	2.70%
Earnings Yield	3.63%
FCF Yield	3.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 3, 2024. It was a forward split with a ratio of 10.

Last Split Date	Oct 3, 2024
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	7